DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Zorzi F, Zuzzi S, Onali S. et al.
Efficacy and safety of infliximab and adalimumab in Crohn’s disease: a single centre study.
Aliment Pharmacol Ther 2012;
35: 1397-1407
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.